Buys
Open market- Shares
- Avg price
- Total value
Stephen Basil Thomas - Director at Climb Bio, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer symbol
- CLYM on Nasdaq
- Entity type
- Individual
- Source evidence
- Open source filing history
Identity
1 fact
SEC evidence
1 fact
Past-year transaction volume for Stephen Basil Thomas in Climb Bio, Inc.
Sells
Open market- Shares
- -150,000
- Avg price
- $5.86
- Total value
- -$879,382
Net
Past year- Shares
- -150,000
- Share %
- -100%
- Total value
- -$879,382
Reported holdings for Stephen Basil Thomas in Climb Bio, Inc.
Form 4 holding
Director
Climb Bio, Inc.
- Security class
- Common Stock
- Shares / value
- 154,657
- Estimated value
- $1,083,526
- Report date
- 26 Feb 2026
- Price
- $7.01
- Ownership
- Direct
Form 4 holding
Director
Climb Bio, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- $32,873
- Report date
- 27 Jun 2025
- Price
- $1.31
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Climb Bio, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 40,000
- Estimated value
- Report date
- 04 Jun 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Stephen Basil Thomas in Climb Bio, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.